BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 34885230)

  • 1. Survival Outcome and Prognostic Factors for Pancreatic Acinar Cell Carcinoma: Retrospective Analysis from the German Cancer Registry Group.
    Petrova E; Wellner J; Nording AK; Braun R; Honselmann KC; Bolm L; Hummel R; Klinkhammer-Schalke M; Zeissig SR; Kleihues van Tol K; Timme-Bronsert S; Bronsert P; Zemskov S; Keck T; Wellner UF
    Cancers (Basel); 2021 Dec; 13(23):. PubMed ID: 34885230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics and treatment analysis of pancreatic acinar cell carcinoma: A single institutional comparison to pancreatic ductal adenocarcinoma.
    Huang X; Li M; Zhang L; Xiong J; Lu H; Tian B
    Surg Oncol; 2021 Jun; 37():101528. PubMed ID: 33611029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics of Resected Acinar Cell Carcinoma of the Pancreas: A Korean Multi-Institutional Study.
    Shin SH; Hwang HK; Jang JY; Kim H; Park SJ; Han SS; Han IW; Hwang DW; Heo JS
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Outcome and Prognostic Factors of Pancreatic Adenosquamous Carcinoma Compared to Ductal Adenocarcinoma-Results from the German Cancer Registry Group.
    Braun R; Klinkhammer-Schalke M; Zeissig SR; Kleihus van Tol K; Bolm L; Honselmann KC; Petrova E; Lapshyn H; Deichmann S; Abdalla TSA; Heckelmann B; Bronsert P; Zemskov S; Hummel R; Keck T; Wellner UF
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
    Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
    Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Effect of Age in Resected Pancreatic Cancer Patients: A Propensity Score Matching Analysis.
    Xu Y; Zhang Y; Han S; Jin D; Xu X; Kuang T; Wu W; Wang D; Lou W
    Front Oncol; 2022; 12():789351. PubMed ID: 35433408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgical resection of hepatic and rectal metastases of pancreatic acinar cell carcinoma (PACC): a case report.
    Ohara Y; Oda T; Enomoto T; Hisakura K; Akashi Y; Ogawa K; Owada Y; Domoto Y; Miyazaki Y; Shimomura O; Kurata M; Ohkohchi N
    World J Surg Oncol; 2018 Aug; 16(1):158. PubMed ID: 30075727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Survival after Resection of Pancreatic Cancer with and without Pancreatic Cysts: Nationwide Registry-Based Study.
    Gorris M; van Huijgevoort NCM; Farina A; Brosens LAA; van Santvoort HC; Groot Koerkamp B; Bruno MJ; Besselink MG; van Hooft JE;
    Cancers (Basel); 2022 Aug; 14(17):. PubMed ID: 36077765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting the NTRK Fusion Gene in Pancreatic Acinar Cell Carcinoma: A Case Report and Review of the Literature.
    Gupta M; Sherrow C; Krone ME; Blais EM; Pishvaian MJ; Petricoin EF; Matrisian LM; DeArbeloa P; Gregory G; Brown A; Zalewski O; Prinzing G; Roche C; Kanehira K; Mukherjee S; Iyer R; Fountzilas C
    J Natl Compr Canc Netw; 2021 Jan; 19(1):10-15. PubMed ID: 33406492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Referral and treatment patterns in pancreatic acinar cell carcinoma: A regional population-level analysis.
    Patel RK; Parappilly M; Sutton TL; Behrens S; Schwantes IR; Johnson AJ; Pommier RF; Sheppard BC
    Am J Surg; 2024 May; 231():55-59. PubMed ID: 37087362
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
    Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
    BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
    Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
    Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two rare cancers of the exocrine pancreas: to treat or not to treat like ductal adenocarcinoma?
    Skorupan N; Ghabra S; Maldonado JA; Zhang Y; Alewine C
    J Cancer Metastasis Treat; 2023; 9():. PubMed ID: 37538977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival after systemic chemotherapy, chemoradiotherapy, and maintenance therapy for an older adult patient with recurrent pancreatic acinar cell carcinoma.
    Urabe M; Ikezawa K; Kozumi K; Kai Y; Takada R; Mukai K; Nakabori T; Uehara H; Akita H; Ohkawa K
    Clin J Gastroenterol; 2024 May; ():. PubMed ID: 38743170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of the preoperative fibrinogen-to-albumin ratio in pancreatic ductal adenocarcinoma patients undergoing R0 resection.
    Zhang LP; Ren H; Du YX; Wang CF
    World J Gastroenterol; 2020 Dec; 26(46):7382-7404. PubMed ID: 33362391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Surgical Resection Significantly Prolong the Long-Term Survival of Patients with Oligometastatic Pancreatic Ductal Adenocarcinoma? A Cross-Sectional Study Based on 18 Registries.
    Li Z; Zhang X; Sun C; Li Z; Fei H; Zhao D
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance for Pancreatic Cancer in High-Risk Individuals Leads to Improved Outcomes: A Propensity Score-Matched Analysis.
    Klatte DCF; Boekestijn B; Onnekink AM; Dekker FW; van der Geest LG; Wasser MNJM; Feshtali S; Mieog JSD; Luelmo SAC; Morreau H; Potjer TP; Inderson A; Boonstra JJ; Vasen HFA; van Hooft JE; Bonsing BA; van Leerdam ME;
    Gastroenterology; 2023 Jun; 164(7):1223-1231.e4. PubMed ID: 36889551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Adjuvant Radiotherapy With Survival After Margin-negative Resection of Pancreatic Ductal Adenocarcinoma: A Propensity-matched National Cancer Database (NCDB) Analysis.
    Kamarajah SK; Sonnenday CJ; Cho CS; Frankel TL; Bednar F; Lawrence TS; Nathan H
    Ann Surg; 2021 Mar; 273(3):587-594. PubMed ID: 30817352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of Tumor Location on Resection and Survival for Pancreatic Ductal Adenocarcinoma.
    Winer LK; Dhar VK; Wima K; Morris MC; Lee TC; Shah SA; Ahmad SA; Patel SH
    J Surg Res; 2019 Jul; 239():60-66. PubMed ID: 30802706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
    Shi HJ; Jin C; Fu DL
    World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.